Search
Muplestim
go.drugbank.com/drugs/DB12431InvestigationalMuplestim is under investigation in clinical trial NCT00002258 (A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL … -3) in HIV Infected Patients With Cytopenia).
Synonyms: IL-3 (NON-GLYCOSYLATED)Categories: Amino Acids, Peptides, and Proteins, Intercellular Signaling Peptides and ProteinsMosapride
go.drugbank.com/drugs/DB11675InvestigationalMosapride is under investigation for the treatment and prevention of Postoperative Ileus and Gastric Peroral Endoscopic Pyloromyotomy (G-POEM). … Mosapride has been investigated for the treatment and diagnostic of Constipation, Type 2 Diabetes, Functional Dyspepsia, Functional Constipation, and Epigastric Pain Syndrome, among others.
Categories: Alimentary Tract and MetabolismNN-8828
go.drugbank.com/drugs/DB18361InvestigationalNN-8828 is an anti-interleukin 21 monoclonal antibody.
Dexpramipexole
go.drugbank.com/drugs/DB15130InvestigationalDexpramipexole is under investigation in clinical trial NCT01511029 (Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured … From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)).
Categories: Compounds used in a research, industrial, or household settingElezanumab
go.drugbank.com/drugs/DB15240InvestigationalElezanumab is under investigation in clinical trial NCT03737812 (A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis).
Categories: Amino Acids, Peptides, and ProteinsFigitumumab
go.drugbank.com/drugs/DB11685InvestigationalFigitumumab has been used in trials studying the treatment of Sarcoma, Solid Tumor, Breast Cancer, Lung Neoplasms, and Advanced Cancer, among others.
Categories: Amino Acids, Peptides, and ProteinsTiragolumab
go.drugbank.com/drugs/DB16409InvestigationalTiragolumab is under investigation in clinical trial NCT04513925 (A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-small
Categories: Amino Acids, Peptides, and ProteinsNasopharyngeal Carcinoma (NPC)
go.drugbank.com/conditions/DBCOND0118910Drugs: TislelizumabSynonyms: CA - Cancer of nasopharynxPI-103
go.drugbank.com/drugs/DB17046ExperimentalPI-103 is an inhibitor of p110α of class I PI3K.[A253092]
Edralbrutinib
go.drugbank.com/drugs/DB18095InvestigationalEdralbrutinib is an orally available small molecule inhibitor of Bruton's tyrosine kinase.